All Upcoming Events
BostonVariational AI at Discovery on Target 2026
Variational AI will participate in Discovery on Target (DOT) 2026, a leading conference dedicated to the latest advances in drug targets and enabling technologies for therapeutic discovery. Held annually in Boston, Discovery on Target brings together scientists from pharma, biotech, and academia to explore emerging approaches for identifying and validating novel drug targets, as well
CologneVariational AI at BIO-Europe 2026
Variational AI will participate in BIO-Europe 2026, one of the world’s leading partnering conferences for the biotechnology and pharmaceutical industries. The event brings together biotech companies, pharmaceutical firms, investors, and technology innovators from across the global life sciences ecosystem to explore partnerships, licensing opportunities, and new approaches to advancing therapeutic development. Meet the Variational AI
All Past Events
TorontoVariational AI at OBIO Investment Summit 2026
We’re happy to share that Variational AI will be participating in the OBIO® Investment Summit in Toronto. Taking place February 3–5, 2026 at Arcadian Court & Loft (401 Bay Street, Simpson Tower, 8th Floor), the OBIO® Investment Summit is Canada’s premier health science investment event, bringing together global investors, strategic partners, and high-growth life sciences
Learn More about Variational AI at OBIO Investment Summit 2026
San FranciscoVariational AI at JPM Week and Biotech Showcase 2026
Each January, the J.P. Morgan Healthcare Conference turns San Francisco into the global epicenter of biotech, pharma, and healthcare investing. It is widely regarded as the industry’s largest and most influential healthcare investment symposium, bringing together global industry leaders, emerging biotech companies, and investors to set the tone for the year ahead. Around the main
Learn More about Variational AI at JPM Week and Biotech Showcase 2026
OnlineWebinar | From Handshake to Breakthrough: How Rakovina & Variational AI are Cracking the Code on CNS-Penetrant Cancer Therapies
Join Rakovina Therapeutics and Variational AI for a 60-minute fireside chat on how deep biology and generative AI are coming together to tackle one of oncology’s toughest problems
ViennaVariational at BIO-Europe 2025
We are pleased to share that Variational will be attending BIO-Europe 2025, Europe’s leading biopharma partnering event. We’ll be there to network with industry leaders, explore strategic partners, and showcase what we’re working on. If you plan on attending, let’s connect!
YokohamaVariational Will Be at BioJapan 2025
Variational is excited to announce that we will be participating in BioJapan 2025, Asia’s premier bio-industry partnering event. We’ll be on site to meet partners, explore collaboration opportunities, and share our latest innovations in biotechnology & drug discovery. Come visit us at our booth to connect in person!
BostonVariational at Discovery on Target 2025
Variational is thrilled to be a part of Discovery on Target 2025, the top conference focused on novel drug targets and emerging discovery technologies. Our Head of Drug Discovery, Peter Guzzo will join peers from around the world to present our last poster and discuss the latest in target validation, biologics & small molecules. Let’s